771 related articles for article (PubMed ID: 19261978)
1. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
[TBL] [Abstract][Full Text] [Related]
2. Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice.
Chwatko G; Boers GH; Strauss KA; Shih DM; Jakubowski H
FASEB J; 2007 Jun; 21(8):1707-13. PubMed ID: 17327360
[TBL] [Abstract][Full Text] [Related]
3. Mutations in cystathionine beta-synthase or methylenetetrahydrofolate reductase gene increase N-homocysteinylated protein levels in humans.
Jakubowski H; Boers GH; Strauss KA
FASEB J; 2008 Dec; 22(12):4071-6. PubMed ID: 18708589
[TBL] [Abstract][Full Text] [Related]
4. The molecular basis of homocysteine thiolactone-mediated vascular disease.
Jakubowski H
Clin Chem Lab Med; 2007; 45(12):1704-16. PubMed ID: 17937605
[TBL] [Abstract][Full Text] [Related]
5. The role of paraoxonase 1 in the detoxification of homocysteine thiolactone.
Jakubowski H
Adv Exp Med Biol; 2010; 660():113-27. PubMed ID: 20221875
[TBL] [Abstract][Full Text] [Related]
6. Genetic or nutritional disorders in homocysteine or folate metabolism increase protein N-homocysteinylation in mice.
Jakubowski H; Perla-Kaján J; Finnell RH; Cabrera RM; Wang H; Gupta S; Kruger WD; Kraus JP; Shih DM
FASEB J; 2009 Jun; 23(6):1721-7. PubMed ID: 19204075
[TBL] [Abstract][Full Text] [Related]
7. Identification and origin of Nε-homocysteinyl-lysine isopeptide in humans and mice.
Głowacki R; Bald E; Jakubowski H
Amino Acids; 2010 Nov; 39(5):1563-9. PubMed ID: 20512599
[TBL] [Abstract][Full Text] [Related]
8. N-Homocysteinylation impairs collagen cross-linking in cystathionine β-synthase-deficient mice: a novel mechanism of connective tissue abnormalities.
Perła-Kajan J; Utyro O; Rusek M; Malinowska A; Sitkiewicz E; Jakubowski H
FASEB J; 2016 Nov; 30(11):3810-3821. PubMed ID: 27530978
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of homocysteine toxicity in humans.
Jakubowski H
Cell Mol Life Sci; 2004 Feb; 61(4):470-87. PubMed ID: 14999406
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and neurotoxicity of homocysteine thiolactone in mice: protective role of bleomycin hydrolase.
Borowczyk K; Tisończyk J; Jakubowski H
Amino Acids; 2012 Sep; 43(3):1339-48. PubMed ID: 22227865
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiological consequences of homocysteine excess.
Jakubowski H
J Nutr; 2006 Jun; 136(6 Suppl):1741S-1749S. PubMed ID: 16702349
[TBL] [Abstract][Full Text] [Related]
12. Chemical biology of homocysteine thiolactone and related metabolites.
Jakubowski H; Głowacki R
Adv Clin Chem; 2011; 55():81-103. PubMed ID: 22126025
[TBL] [Abstract][Full Text] [Related]
13. Modification by homocysteine thiolactone affects redox status of cytochrome C.
Perła-Kaján J; Marczak Ł; Kaján L; Skowronek P; Twardowski T; Jakubowski H
Biochemistry; 2007 May; 46(21):6225-31. PubMed ID: 17474717
[TBL] [Abstract][Full Text] [Related]
14. Paraoxonase 1 protects against protein N-homocysteinylation in humans.
Perla-Kaján J; Jakubowski H
FASEB J; 2010 Mar; 24(3):931-6. PubMed ID: 19880629
[TBL] [Abstract][Full Text] [Related]
15. Homocysteine modulates the effect of simvastatin on expression of ApoA-I and NF-kappaB/iNOS.
Mikael LG; Rozen R
Cardiovasc Res; 2008 Oct; 80(1):151-8. PubMed ID: 18540024
[TBL] [Abstract][Full Text] [Related]
16. Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia.
Li M; Chen J; Li YS; Feng YB; Gu X; Shi CZ
Int J Cardiol; 2006 Jan; 106(2):285-8. PubMed ID: 16183151
[TBL] [Abstract][Full Text] [Related]
17. Homocysteine thiolactone-induced hyperhomocysteinemia does not alter concentrations of cholesterol and SREBP-2 target gene mRNAS in rats.
Stangl GI; Weisse K; Dinger C; Hirche F; Brandsch C; Eder K
Exp Biol Med (Maywood); 2007 Jan; 232(1):81-7. PubMed ID: 17202588
[TBL] [Abstract][Full Text] [Related]
18. [Hyperhomocysteinemia: atherothrombosis and neurotoxicity].
Fridman O
Acta Physiol Pharmacol Ther Latinoam; 1999; 49(1):21-30. PubMed ID: 10797837
[TBL] [Abstract][Full Text] [Related]
19. Protein homocysteinylation: possible mechanism underlying pathological consequences of elevated homocysteine levels.
Jakubowski H
FASEB J; 1999 Dec; 13(15):2277-83. PubMed ID: 10593875
[TBL] [Abstract][Full Text] [Related]
20. Effects of red wine polyphenolic compounds on paraoxonase-1 and lectin-like oxidized low-density lipoprotein receptor-1 in hyperhomocysteinemic mice.
Noll C; Hamelet J; Matulewicz E; Paul JL; Delabar JM; Janel N
J Nutr Biochem; 2009 Aug; 20(8):586-96. PubMed ID: 18676137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
